ReachMD

11/12/2025

Steroids are often a starting point in FSGS management—but for many patients, they’re also the first drug they want to stop.

In this CME, Dr. Lieberman explains how treatment burden and patient experience should shape our decision-making in FSGS. You'll get practical strategies for refining your diagnostic approach, selecting appropriate treatment targets, and understanding the real-world implications of emerging therapies—especially in adult and pediatric populations.

Start the episode: https://ow.ly/jj9n50X8v4z

Focal segmental glomerulosclerosis (FSGS) is a prominent cause of kidney failure globally, necessitating dialysis for patient survival as the...

11/06/2025

Hear Dr. Tesar and Dr. Meghan Sise unpack why today’s FSGS therapies can often fall short and what’s needed next.

Keep watching the full discussion at the link in our bio.

11/06/2025

Tomorrow: MOD Live 2025 at Austin Marriott Downtown. In-person CE, expert panels, and case-based insights across glaucoma, OSD, presbyopia, retina, and more. Last chance to enroll: https://ow.ly/2mzZ50XgrUB

Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75...

10/31/2025

Heading to Austin? Join program chairs Selina McGee, Justin Schweitzer, and Walter Whitley with keynotes Carlo Pelino and Osama Said. Free CE for optometrists. Register: https://ow.ly/KsRB50XgrSp

Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75...

10/30/2025

In this expert-led CME, Dr. Lieberman discusses how treatment burden—especially corticosteroids—shapes patient experience in FSGS.

You’ll also explore how to refine diagnosis, personalize treatment goals, and evaluate the real-world impact of emerging therapies.

Tap the link in bio to start learning.

10/30/2025

Advancing gMG Treatment: Emerging Therapies

10/30/2025

Happening today! Get live insights on FcRn therapies in gMG at AANEM 2025—covering trial data, special populations, and more.

Register for the virtual broadcast: https://ow.ly/E4ZY50XjcSw
Sign up for an in-person seat: https://ow.ly/GRmN50XjcTs

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

10/29/2025

Tomorrow at AANEM: Your guide to FcRn therapies in gMG. Join expert faculty for a focused session on clinical application and key treatment considerations.

Reserve your spot to stream live: https://ow.ly/E4ZY50XjcSw
Be there in person: https://ow.ly/GRmN50XjcTs

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

10/26/2025

FcRn antagonists are reshaping gMG treatment. Get expert insight into mechanisms, trial data, and therapeutic decision-making at AANEM 2025—either at the event or on the live broadcast.

Register to attend virtually: https://ow.ly/oRxJ50XhReq
Join in person: https://ow.ly/Jqqf50XhRfb

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

10/24/2025

How do antibody profiles shape FcRn therapy in gMG? Find out with this expert-led symposium at AANEM 2025, available live on-site or via livestream.

Sign up for online access: https://ow.ly/oRxJ50XhReq
Attend in person at AANEM: https://ow.ly/Jqqf50XhRfb

This symposium, held during the 2025 AANEM Annual Meeting, explores the clinical integration of neonatal Fc receptor (FcRn) antagonists in the...

10/23/2025

Tune in now to hear expert faculty explore current therapies, emerging treatments, and the role of patient-reported outcomes in shaping patient-centered care in FSGS.

This series also examines how evidence-based strategies can be applied across adult and pediatric patients to optimize monitoring and long-term outcomes.

Start listening: https://ow.ly/urGj50X8vXW

Managing patients with focal segmental glomerulosclerosis, or FSGS, can present certain challenges. FSGS is a serious, progressive condition that...

10/22/2025

MOD Live 2025 is live and in person Nov 7–9 in Austin. 8.75 hours of free CE, faculty-led sessions, and practical cases for optometrists. Save your seat: https://ow.ly/5ZPx50Xgryx

Welcome to MOD Live 2025! Join us and be a part of redefining the boundaries in optometry. We're taking clinical education a step further with 8.75 hours of FREE CE, expert panels, collaborative discussions, and numerous networking opportunities.
Gain insights from peers and experts in managing:

g...